Document is current
Any future updates will be listed below
-
Authors
Mok, Rebecca S. F.
Zhang, Wenbo
Sheikh, Taimoor I.
Pradeepan, Kartik https://orcid.org/0000-0003-0979-7928
Fernandes, Isabella R.
DeJong, Leah C. https://orcid.org/0000-0002-0740-8071
Benigno, Gabriel
Hildebrandt, Matthew R. https://orcid.org/0000-0003-0652-3112
Mufteev, Marat
Rodrigues, Deivid C. https://orcid.org/0000-0001-5995-814X
Wei, Wei
Piekna, Alina
Liu, Jiajie
Muotri, Alysson R. https://orcid.org/0000-0003-0867-2875
Vincent, John B. https://orcid.org/0000-0003-0692-2519
Muller, Lyle https://orcid.org/0000-0001-5165-9890
Martinez-Trujillo, Julio https://orcid.org/0000-0003-3338-578X
Salter, Michael W.
Ellis, James https://orcid.org/0000-0002-4400-0091
- License Information
-
More Information
Article History
Received: 16 August 2022
Revised: 1 October 2022
Accepted: 3 October 2022
First Online: 18 October 2022
Competing interests
: ARM is a co-founder and has equity interest in TISMOO, a company dedicated to genetic analysis and brain organoid modeling focusing on therapeutic applications customized for autism spectrum disorder and other neurological disorders with genetic origins. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict of interest policies. MRH became an employee of STEMCELL Technologies Inc during the preparation of this manuscript.
